decisionhealth Newsletters, Part B News - 2005 Issue 3 (March)
Use new immune globulin codes or face denials
Subscribe or sign in to view the full article.
Article Overview
This article is for coders, billing staff, and providers who submit Medicare claims for immune globulin therapy. It covers a CMS transmittal, the move to new Q codes in place of earlier drug codes, related payment updates, and the timing of claim denial changes tied to the effective date. The content is relevant to anyone needing to track Medicare drug coding updates, pricing revisions, and carrier billing rules for immune globulin services.
Why This Topic Matters
The article helps readers identify a Medicare coding update that affects claim processing and payment for immune globulin therapy. Knowing which code set changed and when the new codes apply can help reduce denials and support correct reimbursement handling.
What You Will Learn
- The general purpose of the Medicare immune globulin coding update
- How CMS communicated the change through a transmittal and pricing update
- That payment and billing treatment differ across claim dates and code families
- That carrier billing rules remain relevant to these drug claims
Who Should Read This
- Medical coders
- Billing staff
- Physician office staff
- Oncology practices
- Neurology practices
- Internal medicine practices
- Medicare claims submitters
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com